KRAS and leukemia: A contributing factor may be the high proliferative state of leukemia stem cells (LSCs) in pAML, with activated RAS signaling pathways [23], which could explain the elevated mutation frequencies in RAS pathway genes such as NRAS, KRAS, and PTPN11 [24].